KV
Kalpana Vyas
About Kalpana Vyas
Data last updated:
Kalpana Vyas has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Innov Api Private Limited and Dipti Chemicals And Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Innov Api Private Limited at ₹19.5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 May 2019 | 2019 | ₹19.5 Lakh (FY 2024) | Active | |
| Director | 16 Dec 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalpana Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalpana Vyas
Kalpana Vyas has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Innov Api Private Limited and Dipti Chemicals And Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Innov Api Private Limited at ₹19.5 Lakh (FY 2024).
Kalpana Vyas is associated with 2 companies as Director, including Innov Api Private Limited (₹19.5 Lakh), Dipti Chemicals And Pharmaceuticals Private Limited.
Kalpana Vyas has expertise in General Business.
Kalpana Vyas has 7 years in corporate governance.
By reported revenue, the largest current company of Kalpana Vyas is Innov Api Private Limited, with revenue of ₹19.5 Lakh (FY 2024).
Kalpana Vyas currently holds positions at 2 companies: Innov Api Private Limited (₹19.5 Lakh), Dipti Chemicals And Pharmaceuticals Private Limited.